Laboratoire Mertens B SRL
Laboratoire Mertens B reported total assets of 63,922 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Aug 2026).
The score of Laboratoire Mertens B shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Laboratoire Mertens B's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Aug 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
Laboratoire Mertens B's financial analysis
- Solvency52.2%sector median: 46.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Laboratoire Mertens B
Laboratoire Mertens B's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.800.916
- VAT number
- BE1016800916
- Peppol
- Registered · 0208:1016800916 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Nov 2024
- Registered office
- 1380 Lasne
- Latest accounts
- 2025 · filed on 03 Aug 2026
- Activity
- Manufacture of medical and dental instruments and supplies (NACE 32500)
Laboratoire Mertens B (SRL) has been based in Lasne since 2024, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports a net profit of 27,316 € and equity of 33,344 €; its revenue is not published. Its solvency stands at 52.2%, above the median of its sector (46.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Laboratoire Mertens B
Companies in the same business, of comparable size and area, outside its group.
- Oculoplast Manufacture of medical and dental instruments and supplies Saint-Ghislain · balance sheet 64,920 €
- Smile Concept Manufacture of medical and dental instruments and supplies Rixensart · balance sheet 65,230 €
- Arca & Junco Associes Manufacture of medical and dental instruments and supplies Woluwe-Saint-Lambert · balance sheet 60,928 €
- Optiek CK Manufacture of medical and dental instruments and supplies Hechtel-Eksel · balance sheet 60,636 €
- T.L.C. Manufacture of medical and dental instruments and supplies Haaltert · balance sheet 58,977 €
- Ullys Manufacture of medical and dental instruments and supplies Uccle · balance sheet 72,771 €
- Tandisa Manufacture of medical and dental instruments and supplies Halen · balance sheet 56,123 €
- Labo Dentaire Rotondi Manufacture of medical and dental instruments and supplies Braine-l'Alleud · balance sheet 73,856 €
Frequently asked questions about Laboratoire Mertens B
What is the revenue of Laboratoire Mertens B?
Laboratoire Mertens B files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Laboratoire Mertens B?
In Belgium, the VAT number is the company number prefixed with BE: BE1016800916 for Laboratoire Mertens B, if the company is VAT-registered. Its company number (CBE) is 1016.800.916.
Where is the registered office of Laboratoire Mertens B?
According to the CBE register, the registered office of Laboratoire Mertens B is in 1380 Lasne.
What is the equity of Laboratoire Mertens B?
At the close of the 2025 financial year, the equity of Laboratoire Mertens B amounts to 33,344 €, a solvency of 52.2% of total assets.
Who manages Laboratoire Mertens B?
The register lists 1 active mandates at Laboratoire Mertens B. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Laboratoire Mertens B
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →